Published in Am J Pathol on December 01, 1995
Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop (2006) 1.88
Urokinase type plasminogen activator receptor expression in colorectal neoplasms. Gut (1998) 1.50
Determination of β-glucuronidase in human colorectal carcinoma cell lines. World J Gastroenterol (1997) 0.75
Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res (1985) 8.64
Giant-cell tumor of bone. J Bone Joint Surg Am (1987) 7.92
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J (1990) 3.27
Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am (1982) 2.87
Giant-cell tumor of bone. J Bone Joint Surg Am (1986) 2.78
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem (1991) 2.68
Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem (1991) 2.61
Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol (1991) 2.38
Giant cell tumor of bone. Clin Orthop Relat Res (1986) 1.96
Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol (1990) 1.91
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol (1987) 1.79
Metastases from histologically benign giant-cell tumor of bone. J Bone Joint Surg Am (1984) 1.78
Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Joint Surg Am (1975) 1.74
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol (1991) 1.50
The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases. Trends Biotechnol (1992) 1.50
Benign and malignant giant cell tumors of bone. A clinicopathological analysis of the natural history of the disease. Cancer (1962) 1.43
Giant-cell tumour of bone: an analysis of fifty-two cases. J Bone Joint Surg Br (1972) 1.42
The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem (1986) 1.33
The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev (1992) 1.29
Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest (1987) 1.24
Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J (1986) 1.19
Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol (1987) 1.19
Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res (1991) 1.17
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol (1994) 1.07
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem (1990) 1.04
Ultrastructure of giant cell tumors of bone. Hum Pathol (1972) 1.03
Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol (1994) 1.02
Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone. Am J Pathol (1992) 1.00
Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes. FEBS Lett (1994) 0.99
Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells. FEBS Lett (1994) 0.98
Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone. Cancer (1987) 0.96
Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridization. J Bone Miner Res (1993) 0.90
Biologic characterization of human bone tumors. III. Giant cell tumor of bone. A combined electron microscopical, histochemical, and autoradiographical study. Pathol Res Pract (1984) 0.87
Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme. Eur J Biochem (1989) 0.85
Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study. Cancer (1989) 0.83
Expression of Ia and monocyte-macrophage lineage antigens in giant cell tumor of bone and related lesions. Arch Pathol Lab Med (1988) 0.83
Giant cell tumor bone. Enzyme histochemical, biochemical and tissue culture studies. Virchows Arch A Pathol Anat Histol (1982) 0.83
Giant cell tumor of bone: detailed fine structural analysis of different cell components. Virchows Arch A Pathol Anat Histol (1977) 0.79
Components of the plasminogen-plasmin system in human tumor cell lines. Semin Thromb Hemost (1991) 0.78
Carbonic anhydrase II gene transcript in cultured osteoclasts from neonatal rats: effect of calcitonin. Cell Tissue Res (1994) 0.78
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Explaining variation in general practitioner referrals to hospital. Fam Pract (1987) 10.27
Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science (1997) 8.99
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
Comparison of human genetic and sequence-based physical maps. Nature (2001) 4.97
Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. Br J Cancer (1982) 4.90
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Smoking habits of oral contraceptive users. Lancet (1969) 4.20
Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol (1999) 4.00
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94
Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Sequential Monte Carlo without likelihoods. Proc Natl Acad Sci U S A (2007) 3.42
Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett (1982) 3.42
Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Community Health (1980) 2.95
Classifying spatial patterns of brain activity with machine learning methods: application to lie detection. Neuroimage (2005) 2.92
Preparation, characterization, X-ray crystal structure, and energetics of cesium 5-cyano-1,2,3,4-tetrazolate: Cs[NCCNNNN]. Inorg Chem (2000) 2.91
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta (1998) 2.83
Caesarean scar pregnancy. BJOG (2007) 2.77
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol (2000) 2.75
Retroviruses and poliovaccines. Lancet (1993) 2.74
Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73
Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer (1995) 2.71
Audit commission tackles anaesthetic services. BMJ (1998) 2.70
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Delay in breast cancer and the nature of presenting symptoms. Lancet (1981) 2.67
Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene (2006) 2.60
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J (2003) 2.51
The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care (2005) 2.49
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed) (1986) 2.47
A national health service and the public health. Public Health (1988) 2.46
On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39
Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34
Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Br Dent J (2016) 2.32
Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A (1981) 2.31
Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis (2003) 2.29
Sex pheromone production and perception in European corn borer moths is determined by both autosomal and sex-linked genes. Proc Natl Acad Sci U S A (1987) 2.28
Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor. Science (1989) 2.28
Clinical pharmacology clinics in general practice. Br Med J (1977) 2.28
Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Qualms about QALYs. Lancet (1987) 2.26
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol (1998) 2.20
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14
A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods. Br Dent J (2011) 2.13
Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J (2001) 2.12
The origin, properties and fate of epithelioid cells. J Pathol (1971) 2.12
Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J (2001) 2.08
Outcome of elective prostatectomy. BMJ (1989) 2.08
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Influence of the epithelium on responsiveness of guinea-pig isolated trachea to contractile and relaxant agonists. Br J Pharmacol (1986) 2.07
Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev (1994) 2.07
Sequence of the preprotoxin dsRNA gene of type I killer yeast: multiple processing events produce a two-component toxin. Cell (1984) 2.03
A verandah-trap hut for studying the house-frequenting habits of mosquitoes and for assessing insecticides. 3. The effect of DDT on behavior and mortality. Bull Entomol Res (1969) 2.03
The management of acute abdominal pain in children. J Paediatr Child Health (1996) 2.02
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. Am J Pathol (2000) 1.99
Does the presence of a cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case-control study. Ultrasound Obstet Gynecol (2012) 1.98
Development of PCR assays for species- and type-specific identification of Pasteurella multocida isolates. J Clin Microbiol (1998) 1.97
The Polycomb group in Caenorhabditis elegans and maternal control of germline development. Development (1998) 1.97
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res (1996) 1.95
The economic value of contraception: a comparison of 15 methods. Am J Public Health (1995) 1.95
The cardiac conduction system in situs ambiguus. Circulation (1979) 1.92
"Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry (1998) 1.90
Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ (1989) 1.89
Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation (1998) 1.89
Sleep and behavior problems among preschoolers. J Dev Behav Pediatr (1999) 1.86
Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr (2001) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology (2004) 1.82
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82
Atresia of the right atrioventricular orifice. Br Heart J (1977) 1.82
Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro. J Virol Methods (1993) 1.82
Critical incident reports concerning anaesthetic equipment: analysis of the UK National Reporting and Learning System (NRLS) data from 2006-2008*. Anaesthesia (2011) 1.81
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol (1989) 1.80
Vocational training for general practice: a preliminary report. Br Med J (1971) 1.79
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst (1998) 1.78
Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76
Psychosocial, lifestyle, and health status variables in predicting high attendance among adults. Br J Gen Pract (2001) 1.76
The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res (1993) 1.74
Essential function of LIF receptor in motor neurons. Nature (1995) 1.74
Risk of scrapie in British sheep of different prion protein genotype. J Gen Virol (2004) 1.73